您当前的位置:
首页 >
文章列表页 >
CA916798 gene is involved in cisplatin resistance in human lung cancer through PI3K/AKT pathway
更新时间:2026-01-09
    • CA916798 gene is involved in cisplatin resistance in human lung cancer through PI3K/AKT pathway

    • Journal of Army Medical University   Vol. 35, Issue 7, Pages: 618-621(2013)
    • CLC: R73-361;R734.2;R979.11
    • Published:2013

    移动端阅览

  •  Zhu Bingjing,Wang Yuliang,Luo Hu,Zhou Xiangdong.CA916798 gene is involved in cisplatin resistance in human lung cancer through PI3K/AKT pathway[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(07):618-621. DOI:

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Investigation on expression pattern of multidrug resistance-associated gene in human small cell lung cancer cell lines SH77/CDDP using gene chip technique
Z-Ligustilide ameliorates retinitis pigmentosa via inhibiting PI3K/AKT-inflammation axis: Validation based on network pharmacology and molecular docking
Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells
Amifostine enhances the resistance of renal proximal tubular epithelial cells to cisplatin by upregulating PKM2
Silencing high mobility group protein B1 inhibits malignant biological behavior of glioblastoma cells

Related Author

周向东
钱桂生
刘凌志
XIAO Weizuo
GE Lingling
A Luodan
DENG Jiaxing
HUO Shujia

Related Institution

Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Ophthalmology, General Hospital of Southern Theater Command
Department of Gastroenterology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, Third Military Medical University
0